European Management of Glanzmann’s Thrombasthenia from EAHAD’s Working Group
European Association for Haemophilia and Allied Disorders (EAHAD) shared on LinkedIn:
”Care for Glanzmann’s thrombasthenia still varies widely across Europe, from antibody screening practices to access to HLA-matched platelets.
A new publication from the EAHAD Glanzmann Thrombasthenia Working Group highlights areas of agreement and where further alignment is needed.
Read more on the Haemophilia Journal.”
Read the full article in Haemophilia Journal.
Article: European Management of Glanzmann’s Thrombasthenia: A Survey of Current Clinical Practice
Authors: Mathieu Fiore, Andrea Artoni, Robert Klamroth, Mary Mathias, Roger Schutgens, Roseline d’Oiron, EAHAD Glanzmann Thrombasthenia Working Group
Stay updated on all scientific advances in the field of platelet disorders with Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia